The Pathways to Prosperity Act creates a new grant program to strengthen workforce development at community colleges. It provides competitive grants to community colleges to develop programs that prepare students for high-skill, high-wage jobs through partnerships with employers in growing industries. The bill requires colleges to use proven methods, create credentials that can be used across different jobs or built upon for further training, and track outcomes like program completion and job advancement. It also establishes performance metrics for program evaluation and requires transparent public reporting of results. This legislation primarily affects community colleges, students, and workers seeking career advancement in specific industry sectors.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
This bill directs the U.S. Department of Health and Human Services to fund research on early detection and treatment of uterine fibroids (non-cancerous uterine tumors) and to award grants to states. The grants will support state programs that increase early detection through screening (like advanced imaging), patient navigation services, public education campaigns, and implementing research-backed strategies. It also requires additional research on disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. States receiving grants must report on program outcomes and research findings to Congress every two years. The bill directly affects healthcare systems, providers, and patients - particularly those facing disparities in gynecological care - by expanding access to early detection services.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.
Deporting Fraudsters Act of 2026 This bill makes certain acts related to public benefits fraud grounds for (1) barring a non-U.S. national ( alien under federal law) from admission into the United States, or (2) deporting the individual. The bill also makes such an individual ineligible for immigration enforcement relief, including relief for an individual in danger of subjection to torture. Specifically, this bill applies to individuals who have been convicted of, admit to having committed, or admit to acts which constitute certain offenses. Offenses covered by this bill include (1) fraud involving Supplemental Nutrition Assistance Program (SNAP) benefits, (2) fraud involving Social Security benefits, (3) fraud involving programs that receive federal funds, and (4) the production of fraudulent identification documents.
HR 556, the Protecting Access for Hunters and Anglers Act, prevents federal agencies from banning lead ammunition or tackle on public lands and waters managed for hunting or fishing. It directly affects hunters and anglers using federal lands (like national wildlife refuges, public forests, and BLM lands) by blocking nationwide restrictions on lead products. The bill allows limited exceptions only for specific locations where wildlife decline is directly linked to lead use, and the restriction must align with state law or get approval from the state wildlife agency. This changes how federal land managers can regulate lead, requiring state coordination for any local restrictions.
This bill, titled the Stop Insider Trading Act, would restrict Members of Congress and their spouses and dependents from purchasing stocks in publicly traded companies. It requires these individuals to provide advance public notice at least seven days before selling any covered investments, with the notice filed with the Clerk of the House or Secretary of the Senate. The law includes exceptions for certain occupational transactions and reinvested dividends, and establishes penalties including fees and mandatory sales for violations.
The Energy Bills Relief Act aims to lower household energy costs and accelerate the development of low-cost, clean energy by modifying federal tax credits, expanding weatherization programs, and streamlining permitting processes. Key provisions include restoring tax incentives for renewable energy projects, increasing funding for low-income heating assistance, and requiring federal agencies to treat wind, solar, and storage projects with the same procedural fairness as oil and gas projects. The bill also establishes new incentives for upgrading the electricity grid, such as tax credits for transmission lines and grants for wildfire prevention measures, while creating mechanisms to ensure utilities serve public interests and protect consumers from price volatility.
This bill expands eligibility for temporary lodging at VA Fisher Houses to include more veterans' families and caregivers traveling for medical care. It adds new categories allowing family members of veterans or active-duty service members (defined as "eligible individuals") to stay at Fisher Houses "on a space-available basis" when they travel significant distances for VA or non-VA medical care. The bill also clarifies that "Fisher Houses" are facilities near VA medical centers, donated by the Fisher Foundation, and available for temporary stays by patients and their support networks. This change directly affects veterans, active-duty service members, and their families needing short-term housing during medical treatment.
This bill requires the VA to create and maintain a standardized list (the "Formulary") of covered prosthetic and rehabilitative items and services for veterans. It mandates that the VA develop this list using evidence-based research, ensure all listed items are available at every VA facility nationwide, and regularly update and publish the Formulary online. Veterans will receive clear communication about covered items and how to appeal denied requests, while VA clinicians can still prescribe non-Formulary items when medically necessary, with oversight to evaluate if those items should be added to the Formulary. The policy directly affects veterans receiving prosthetic care through the VA system.
